SEC 13F Intelligence

CORBUS PHARMACEUTICALS HLDGS

CUSIP 21833P103

Corbus Pharmaceuticals Hldgs has 1 institutional holders in Filings Flow’s 13F database, together reporting 0 shares worth $0 as of Q2 2025.

Institutional Holders
1
Q2 2025
Reported Value
$0
Ticker
unmapped
private placement or foreign
Quarters Tracked
26

Ownership Trend

Institutional holders
Q1 ’19: 81Q1 ’19Q2 ’19: 82Q3 ’19: 81Q4 ’19: 87Q1 ’20: 90Q1 ’20Q2 ’20: 119Q3 ’20: 96Q4 ’20: 86Q1 ’21: 90Q1 ’21Q2 ’21: 80Q3 ’21: 69Q4 ’21: 59Q1 ’22: 53Q1 ’22Q2 ’22: 49Q3 ’22: 44Q4 ’22: 50Q1 ’23: 3Q1 ’23Q2 ’23: 1Q3 ’23: 1Q4 ’23: 1Q1 ’24: 1Q1 ’24Q2 ’24: 1Q3 ’24: 1Q4 ’24: 1Q1 ’25: 1Q1 ’25Q2 ’25: 1filingsflow.com
Total reported value
Q1 ’19: $77MQ1 ’19Q2 ’19: $139MQ3 ’19: $91MQ4 ’19: $104MQ1 ’20: $106MQ1 ’20Q2 ’20: $242MQ3 ’20: $47MQ4 ’20: $37MQ1 ’21: $47MQ1 ’21Q2 ’21: $70MQ3 ’21: $33MQ4 ’21: $21MQ1 ’22: $17MQ1 ’22Q2 ’22: $6MQ3 ’22: $3MQ4 ’22: $465,185Q1 ’23: $15,330Q1 ’23Q2 ’23: $0Q3 ’23: $0Q4 ’23: $0Q1 ’24: $0Q1 ’24Q2 ’24: $0Q3 ’24: $0Q4 ’24: $0Q1 ’25: $0Q1 ’25Q2 ’25: $0filingsflow.com

Holders

Export to Excel
Manager% of PortfolioValueSharesQuarter
No holders match this filter.

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.